Press and Media
The latest news and press resources
The latest news and press resources
DrugBank announced their partnership with the American Society of Health-System Pharmacists (ASHP). This move will combine both organization’s strengths at delivering reliable, trusted data and open the door for product development collaborations to address industry gaps.
Now, with $9 million CAD in seed financing led by Montréal-based Brightspark Ventures, and supported by a group of strategic investors from the precision medicine and pharma spaces, DrugBank is ready to grow its team and expand its AI capabilities.
Four days of events will feature keynotes and talks from leaders in AI and machine learning. Amii (the Alberta Machine Intelligence Institute) has announced the program for AI Week, May 24-27 in Edmonton, Canada.
The Edmonton-based company’s debut at 19th in the under 50 employees category closely follows its success in raising $9 million of seed funding, led by Brightspark Ventures, earlier this month.
An Edmonton start-up company is getting recognition for its cutting edge technology that can help in emergency situations.
DrugBank, the world's most complete and up-to-date pharmaceutical knowledge database, expands coverage to better serve global customers.
Now, with $9 million CAD in seed financing led by Montréal-based Brightspark Ventures, and supported by a group of strategic investors from the precision medicine and pharma spaces, DrugBank is ready to grow its team and expand its AI capabilities.
Accelerate Fund II is excited to announce its investment in DrugBank, an Edmonton company that has developed a comprehensive, online knowledge base of essential information on drugs and drug targets.
On March 29th, our team announced a $500,000 pool of funds to be awarded in $10,000 - $25,000 grants to startups that are using data science, machine learning, and artificial intelligence to find solutions for the myriad challenges created by COVID-19.
DrugBank, which offers “a unique bioinformatics and cheminformatics resource that combines detailed drug data with comprehensive drug target information,” won the $125,000 Startup TNT Investment Summit pitch competition last week.
DrugBank is the world’s first intelligent and comprehensive drug knowledge platform. With the help of artificial intelligence, our expert team authors, verifies, and structures all of the latest biomedical information so that it can be used to its fullest potential.
DrugBank is the world’s first intelligent and comprehensive drug knowledge platform. With the help of artificial intelligence, our team of medical and scientific experts gather, author, verify, and structure all of the latest biomedical information into one knowledge platform. We make this platform easy to access through DrugBank Online (our free-to-use website), data downloads, or software integrations.
Our goal is to augment human intelligence so that all medical information is used to its fullest potential, because we want to ensure that everyone in the world has access to the best possible medical outcomes.
Get our brand assets kit, including logos and usage guide to help determine when and how to utilize our brand.
Download Assets
From our Clinical API to Drug Datasets,
DrugBank has what you need